368 related articles for article (PubMed ID: 19879523)
1. A curious case of anti-D antibody titer.
Hensley JG; Coughlin KP; Klein LL
J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
[TBL] [Abstract][Full Text] [Related]
2. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report.
Seeho SK; Burton G; Leigh D; Marshall JT; Persson JW; Morris JM
Hum Reprod; 2005 Mar; 20(3):697-701. PubMed ID: 15661826
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
[TBL] [Abstract][Full Text] [Related]
4. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
5. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
[TBL] [Abstract][Full Text] [Related]
6. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
7. RhD haemolytic disease of the fetus and the newborn.
Urbaniak SJ; Greiss MA
Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
[TBL] [Abstract][Full Text] [Related]
8. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
[TBL] [Abstract][Full Text] [Related]
9. The use of maternal plasma for prenatal RhD blood group genotyping.
Finning K; Martin P; Daniels G
Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
[TBL] [Abstract][Full Text] [Related]
10. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive prenatal diagnosis and determination of fetal Rh status.
van der Schoot CE; Hahn S; Chitty LS
Semin Fetal Neonatal Med; 2008 Apr; 13(2):63-8. PubMed ID: 18249590
[TBL] [Abstract][Full Text] [Related]
12. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
Moise KJ
Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
[TBL] [Abstract][Full Text] [Related]
13. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
[TBL] [Abstract][Full Text] [Related]
14. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
[TBL] [Abstract][Full Text] [Related]
15. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
16. [The importance of laboratory diagnosis in allo-immunization through pregnancy and hemolytic disease of the newborn].
Florea DP
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):211-3. PubMed ID: 20509304
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.
Bianchi DW; Avent ND; Costa JM; van der Schoot CE
Obstet Gynecol; 2005 Oct; 106(4):841-4. PubMed ID: 16199645
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
[TBL] [Abstract][Full Text] [Related]
19. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
[TBL] [Abstract][Full Text] [Related]
20. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
Daniels G; Finning K; Martin P; Summers J
Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
